IMPACT OF ACUTE ANTIBIOTIC USAGE ON THE PULMONARY EXACERBATION ENDPOINT IN A CYSTIC FIBROSIS RANDOMIZED TRIAL

被引：0
|
作者：
Hamblett, N. M. [1 ,2 ]
Saiman, L. [3 ]
Kloster, M. [2 ]
Anstead, M. [4 ]
Lands, L. C. [5 ]
Fisher, L. [2 ]
Ratjen, F. [6 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Seattle Childrens Hosp, Seattle, WA USA
[3] Columbia Univ, New York, NY USA
[4] Childrens Hosp, Lexington, KY USA
[5] McGill Univ, Montreal, PQ, Canada
[6] Univ Toronto, Toronto, ON, Canada
来源：
PEDIATRIC PULMONOLOGY | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：292 / 292
页数：1
相关论文
共 50 条
  • [21] The role of procalcitonin as a biomarker for acute pulmonary exacerbation in subjects with cystic fibrosis and non-cystic fibrosis bronchiectasis
    Mammadov, Firuz
    Olgun Yildizel, Sehnaz
    Kocakaya, Derya
    Arikan, Huseyin
    Cinar, Caner
    Eryuksel, Emel
    Ceyhan, Berrin
    MARMARA MEDICAL JOURNAL, 2022, 35 (02): : 164 - 171
  • [22] Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: The early intervention in cystic fibrosis exacerbation (eICE) trial
    Lechtzin, N.
    West, N.
    Allgood, S.
    Wilhelm, E.
    Khan, U.
    Mayer-Hamblett, N.
    Aitken, M. L.
    Ramsey, B. W.
    Boyle, M. P.
    Mogayzel, P. J., Jr.
    Goss, C. H.
    CONTEMPORARY CLINICAL TRIALS, 2013, 36 (02) : 460 - 469
  • [23] Predictors of pulmonary exacerbation treatment in cystic fibrosis
    Sanders, Don B.
    Ostrenga, Joshua S.
    Rosenfeld, Margaret
    Fink, Aliza K.
    Schechter, Michael S.
    Sawicki, Gregory S.
    Flume, Patrick A.
    Morgan, Wayne J.
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (03) : 407 - 414
  • [24] Defining an exacerbation of pulmonary disease in cystic fibrosis
    Dakin, C
    Henry, RL
    Field, P
    Morton, J
    PEDIATRIC PULMONOLOGY, 2001, 31 (06) : 436 - 442
  • [25] WHAT IS A PULMONARY EXACERBATION IN CYSTIC-FIBROSIS
    WOOD, RE
    LEIGH, MW
    JOURNAL OF PEDIATRICS, 1987, 111 (06): : 841 - 842
  • [26] PREDICTORS OF PULMONARY EXACERBATION TREATMENT IN CYSTIC FIBROSIS
    Ostrenga, J.
    Sanders, D. B.
    Rosenfeld, M.
    Fink, A.
    Schechter, M. S.
    Sawicki, G. S.
    Flume, P.
    Morgan, W. J.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S383 - S383
  • [27] Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary Exacerbation
    Kidd, James M.
    Sakon, Colleen M.
    Oleksiuk, Louise-Marie
    Cies, Jeffrey J.
    Pettit, Rebecca S.
    Nicolau, David P.
    Kuti, Joseph L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (01)
  • [28] Acute pulmonary exacerbation is not associated with increased energy expenditure in children with cystic fibrosis
    Stallings, VA
    Fung, EB
    Hofley, PM
    Scanlin, TF
    JOURNAL OF PEDIATRICS, 1998, 132 (03): : 493 - 499
  • [29] Evaluation of functional capacity and pulmonary functions during acute pulmonary exacerbation in children with cystic fibrosis
    Kilic, Kubra
    Vardar-Yagli, Naciye
    Saglam, Melda
    Inal-Ince, Deniz
    Yalcin, Ebru
    Ademhan-Tural, Dilber
    Dogru, Deniz
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [30] Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial
    Horita, Nobuyuki
    Takeshi, Kaneko
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (01) : 150 - 151
12345